Cellectar Biosciences's total assets for Q1 2026 were $11.12M, a decrease of -25.76% from the previous quarter. CLRB total liabilities were $6.40M for the fiscal quarter, a 26.56% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.